Cargando…
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis
OBJECTIVE: To develop and evaluate an adjusted score for the multi-biomarker disease activity (MBDA) test to account for the effects of age, sex and adiposity in patients with RA. METHODS: Two models were developed to adjust MBDA score for age, sex and adiposity, using either serum leptin concentrat...
Autores principales: | Curtis, Jeffrey R, Flake, Darl D, Weinblatt, Michael E, Shadick, Nancy A, Østergaard, Mikkel, Hetland, Merete Lund, Brahe, Cecilie Heegaard, Hwang, Yong Gil, Furst, Daniel E, Strand, Vibeke, Etzel, Carol J, Pappas, Dimitrios A, Wang, Xingbin, Hwang, Ching Chang, Sasso, Eric H, Gutin, Alexander, Hitraya, Elena, Lanchbury, Jerry S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477524/ https://www.ncbi.nlm.nih.gov/pubmed/30590790 http://dx.doi.org/10.1093/rheumatology/key367 |
Ejemplares similares
-
Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies
por: Curtis, Jeffrey R., et al.
Publicado: (2021) -
Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients
por: Curtis, Jeffrey R., et al.
Publicado: (2020) -
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
por: Terslev, Lene, et al.
Publicado: (2021) -
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020) -
Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al
por: Curtis, Jeffrey R., et al.
Publicado: (2017)